Table 3.
Clinicopathological characteristics from shorter survival to longer survival time of 12 patients who lived more than 5 years after diagnosis of gliomatosis cerebri. Abbreviations: OS = overall survival; DA‐IDHwt = Diffuse astrocytoma, IDH‐wildtype; DA‐IDHmt = Diffuse astrocytoma, IDH‐mutant; AA‐IDHwt = Anaplastic astrocytoma, IDH‐wildtype; AA‐IDHmt = Anaplastic astrocytoma, IDH‐mutant; F = female; M = male; Rx = resection; RT = radiotherapy; TMZ = temozolomide; Bx = biopsy; CTx = nitrosourea‐based chemotherapy.
| No. | WHO2016 | OS (month) | Survival | Sex | Age (year) | Growth type | Treatment† |
|---|---|---|---|---|---|---|---|
| 1 | AA‐IDHmt | 61 | Alive | M | 42 | Type 2 | Rx |
| 2 | AA‐IDHmt | 63 | Died | M | 28 | Type 2 | Bx RT |
| 3 | DA‐IDHwt | 63 | Died | M | 52 | Type 1 | Rx RT |
| 4 | DA‐IDHwt | 76 | Alive | F | 48 | Type 2 | Rx RT CTx TMZ |
| 5 | AA‐IDHwt | 77 | Alive | M | 40 | Type 1 | Bx TMZ |
| 6 | AA‐IDHwt | 82 | Died | F | 49 | Type 1 | Bx RT CTx TMZ |
| 7 | AA‐IDHwt | 91 | Died | M | 55 | Type 2 | Rx RT TMZ |
| 8 | AA‐IDHwt | 92 | Alive | M | 15 | Type 1 | Bx RT CTx |
| 9 | AA‐IDHmt | 93 | Died | F | 28 | Type 2 | Rx RT TMZ |
| 10 | DA‐IDHmt | 119 | Alive | M | 68 | Type 1 | Bx RT TMZ |
| 11 | AA‐IDHwt | 126 | Alive | F | 49 | Type 2 | Rx RT GKS TMZ |
| 12 | DA‐IDHwt | 128 | Alive | F | 51 | Type 2 | Bx Bx RT CTx TMZ |
†
Treatment includes the overall treatment after initial biopsy or resection before follow‐up biopsy.